NCT00629239 - Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

AZD4818

Dry Powder, inhalation, b.i.d., 4 weeks

DRUG

Placebo

Trial Locations (12)

Research Site, Hvidovre

Research Site, København NV

Research Site, Odense C

Research Site, Helsinki

Research Site, Preitilä

Research Site, Tampere

Research Site, Breda

Research Site, Groningen

Research Site, Elverum

Research Site, Oslo

Research Site, Trondheim

Research Site, Lund